marketcaparena
Search

    URGN

    UroGen Pharma Ltd.

    Company overview

    Market capitalization
    $2.00B
    Employees
    298
    Latest publication
    2026-09-29
    About UroGen Pharma Ltd.

    UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; Mitomycin a generic drug used off-label as an adjuvant chemotherapy for the treatment of low-grade NMIBC after trans-urethral resection of bladder tumor; Zusduri, a sustained-release formulation of mitomycin for the treatment of non-muscle invasive bladder cancer (NMIBC); and Jelmyto for pyelocalyceal solutions. The company's lead product candidates are UGN-103, which is in phase 3 of clinical trial for intravesical solution; and UGN-104 that is in phase 3 of clinical trial for pyelocalyceal solution designed for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk NMIBC. It is also developing UGN-301, UGN-301+UGN 201, and UGN-301+gemcitabine that are in phase 1 of clinical trial for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 and UGN-104. UroGen Pharma Ltd. was incorporated in 2004 and is headquartered in Princeton, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20202020-12-31 · USDQ3 20202020-09-30 · USDQ2 20202020-06-30 · USDQ1 20202020-03-31 · USDQ4 20192019-12-31 · USDQ3 20192019-09-30 · USDQ2 20192019-06-30 · USD
    Total Revenue72,456,000USD7,966,000USD3,461,000USD372,000USD0USD0USD0USD18,000USD
    Cost Of Revenue6,572,000USD652,000USD309,000USD48,000USD0USD0USD23,453,000USD0USD
    Gross Profit65,884,000USD7,314,000USD3,152,000USD324,000USD0USD0USD-23,453,000USD18,000USD
    Research Development17,336,000USD12,405,000USD10,211,000USD8,106,000USD16,588,000USD20,094,000USD9,481,000USD9,996,000USD
    Selling General Administrative48,437,000USD22,163,000USD22,065,000USD24,018,000USD21,973,000USD19,745,000USD13,972,000USD13,775,000USD
    Total Operating Expenses65,773,000USD34,568,000USD32,276,000USD32,124,000USD38,561,000USD39,839,000USD23,453,000USD23,771,000USD
    Operating Income111,000USD-27,254,000USD-29,124,000USD-31,800,000USD-38,561,000USD-39,839,000USD-23,453,000USD-23,753,000USD
    Total Other Income Expense Net-8,833,000USD102,000USD308,000USD451,000USD768,000USD866,000USD1,201,000USD1,276,000USD
    Income Before Tax-8,722,000USD-27,152,000USD-28,816,000USD-31,349,000USD-37,793,000USD-38,973,000USD-22,252,000USD-22,477,000USD
    Income Tax Expense5,629,000USD3,374,000USD————-245,000USD-246,000USD
    Net Income-14,351,000USD-30,526,000USD-28,816,000USD-31,349,000USD-37,793,000USD-38,973,000USD-22,252,000USD-22,477,000USD
    Interest Income—267,000USD308,000USD451,000USD811,000USD1,006,000USD1,257,000USD1,343,000USD
    Net Interest Income—102,000USD308,000USD451,000USD768,000USD1,150,000USD1,201,000USD1,276,000USD
    Tax Provision—3,374,000USD——————
    Net Income From Continuing Ops—-30,526,000USD-29,124,000USD-31,349,000USD-37,793,000USD-38,973,000USD-22,252,000USD-22,477,000USD
    Ebit—-27,254,000USD-29,124,000USD-31,800,000USD-37,750,000USD-39,839,000USD-23,698,000USD-24,059,000USD
    Ebitda—-26,639,000USD-29,007,000USD-31,325,000USD-37,294,000USD-38,703,000USD-23,388,000USD-23,753,000USD
    Depreciation And Amortization—615,000USD117,000USD475,000USD456,000USD1,136,000USD310,000USD306,000USD
    Reconciled Depreciation—615,000USD498,000USD475,000USD456,000USD1,136,000USD65,000USD60,000USD
    Net Income Applicable To Common Shares—-30,526,000USD-28,816,000USD-31,349,000USD-37,793,000USD-38,973,000USD-22,252,000USD-22,477,000USD
    Interest Expense————43,000USD4,332,000USD—1,276,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20202020-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USD
    Total Revenue11,799,000USD8,158,000USD17,530,000USD0USD0USD0USD
    Cost Of Revenue1,009,000USD600,000USD28,000USD113,000USD0USD0USD
    Gross Profit10,790,000USD7,558,000USD17,502,000USD-113,000USD0USD0USD
    Research Development47,310,000USD18,697,000USD10,287,000USD10,515,000USD4,008,000USD2,334,000USD
    Selling General Administrative90,219,000USD8,811,000USD6,417,000USD1,895,000USD890,000USD1,055,000USD
    Total Operating Expenses137,529,000USD27,508,000USD16,704,000USD12,410,000USD4,356,000USD3,389,000USD
    Operating Income-126,739,000USD-19,950,000USD798,000USD-12,410,000USD-4,369,000USD-3,389,000USD
    Interest Income1,986,000USD31,000USD2,739,000USD279,000USD——
    Interest Expense3,673,000USD0USD0USD0USD0USD0USD
    Net Interest Income1,629,000USD-31,000USD-2,739,000USD———
    Income Before Tax-125,110,000USD-19,981,000USD-1,941,000USD-12,689,000USD-4,476,000USD-3,306,000USD
    Income Tax Expense3,374,000USD19,000USD0USD0USD81,000USD0USD
    Tax Provision3,374,000USD19,000USD————
    Net Income-128,484,000USD-20,000,000USD-1,941,000USD-12,689,000USD-4,557,000USD-3,306,000USD
    Net Income From Continuing Ops-128,484,000USD-20,000,000USD-1,941,000USD-12,689,000USD-4,476,000USD-3,306,000USD
    Ebit-126,739,000USD-19,950,000USD798,000USD-12,410,000USD-4,369,000USD-3,389,000USD
    Ebitda-124,695,000USD-19,743,000USD1,011,000USD-12,297,000USD-4,339,000USD-3,371,000USD
    Depreciation And Amortization2,044,000USD207,000USD213,000USD113,000USD30,000USD18,000USD
    Reconciled Depreciation2,044,000USD207,000USD————
    Total Other Income Expense Net1,629,000USD-31,000USD-2,739,000USD-279,000USD-107,000USD83,000USD
    Net Income Applicable To Common Shares-128,484,000USD-20,825,000USD-4,408,000USD-13,541,000USD-4,557,000USD-3,306,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets252,590,000USD253,690,000USD200,455,000USD185,046,000USD208,717,000USD247,618,000USD285,711,000USD301,943,000USD
    Cash And Equivalents79,133,000USD———————
    Total Current Assets235,426,000USD237,464,000USD186,024,000USD168,546,000USD196,868,000USD237,177,000USD276,135,000USD295,097,000USD
    Other Current Assets12,776,000USD19,530,000USD16,022,000USD13,469,000USD13,137,000USD14,059,000USD9,921,000USD15,126,000USD
    Other Non Current Assets8,761,000USD———————
    Total Liabilities384,986,000USD———————
    Total Current Liabilities61,915,000USD50,635,000USD46,418,000USD42,244,000USD47,548,000USD42,000,000USD45,949,000USD32,787,000USD
    Other Current Liabilities7,622,000USD———————
    Total Stockholder Equity-132,396,000USD-124,253,000USD-105,474,000USD-115,408,000USD-93,376,000USD-46,458,000USD-8,803,000USD25,515,000USD
    Total Equity Including Noncontrolling Interest-132,396,000USD———————
    Long Term Debt188,734,000USD189,530,000USD122,210,000USD122,111,000USD122,508,000USD122,108,000USD121,734,000USD121,709,000USD
    Net Receivables88,757,000USD55,412,000USD33,082,000USD19,703,000USD19,649,000USD19,638,000USD20,302,000USD22,802,000USD
    Inventory24,589,000USD20,921,000USD16,464,000USD8,340,999USD7,128,000USD7,590,000USD9,227,000USD7,594,000USD
    Property Plant Equipment Net3,407,000USD8,556,000USD9,093,000USD9,184,000USD6,239,000USD5,380,000USD3,789,000USD1,660,000USD
    Accounts Payable39,945,000USD17,209,000USD12,137,000USD10,279,000USD13,564,000USD14,567,000USD10,931,000USD5,556,000USD
    Short Term Debt684,000USD1,916,000USD—1,588,000USD1,548,000USD1,414,000USD3,060,000USD825,000USD
    Common Stock135,000USD134,000USD133,000USD128,000USD126,000USD126,000USD115,000USD115,000USD
    Retained Earnings-997,641,000USD-983,290,000USD-959,716,000USD-933,352,000USD-900,005,000USD-850,065,000USD-806,222,000USD-768,710,000USD
    Accumulated Other Comprehensive Income-2,000USD8,000USD19,000USD23,000USD5,999USD14,000USD56,000USD236,000USD
    Total Liab—377,943,000USD305,929,000USD300,454,000USD302,093,000USD294,076,000USD294,514,000USD276,428,000USD
    Other Current Liab—23,232,000USD34,281,000USD30,377,000USD32,436,000USD27,433,000USD35,018,000USD27,231,000USD
    Capital Stock—134,000USD133,000USD128,000USD126,000USD126,000USD115,000USD115,000USD
    Other Assets—113,416,000USD——————
    Cash—111,295,000USD110,745,000USD90,039,000USD92,904,000USD104,033,000USD171,987,000USD124,916,000USD
    Cash And Short Term Investments—141,601,000USD120,456,000USD127,033,000USD156,954,000USD195,890,000USD236,685,000USD249,575,000USD
    Current Deferred Revenue—8,278,000USD—7,700,000USD——5,151,000USD7,695,000USD
    Net Debt—85,798,000USD17,587,000USD39,901,000USD34,565,000USD20,916,000USD-48,600,000USD-2,995,000USD
    Short Long Term Debt Total—197,093,000USD128,332,000USD129,940,000USD127,469,000USD124,949,000USD123,387,000USD121,921,000USD
    Short Term Investments—30,306,000USD9,711,000USD36,994,000USD64,050,000USD91,857,000USD64,698,000USD124,659,000USD
    Property Plant Equipment Gross—13,218,000USD13,680,000USD13,697,000USD10,672,000USD9,733,000USD8,070,000USD5,873,000USD
    Common Stock Shares Outstanding—50,182,758shares49,230,277shares48,057,386shares47,739,816shares47,422,119shares47,030,820shares43,100,237shares
    Non Current Assets Total—16,226,000USD14,431,000USD16,500,000USD11,849,000USD10,441,000USD9,576,000USD6,846,000USD
    Non Current Liabilities Total—327,308,000USD259,511,000USD258,210,000USD254,545,000USD252,076,000USD248,565,000USD243,641,000USD
    Non Currrent Assets Other—7,493,000USD5,161,000USD6,936,000USD978,000USD547,000USD765,000USD545,000USD
    Net Working Capital—186,829,000USD139,606,000USD126,302,000USD149,320,000USD195,177,000USD230,186,000USD262,310,000USD
    Unclassified Non Current Assets—-113,239,000USD——————
    Unclassified Non Current Liabilities—137,778,000USD137,301,000USD136,099,000USD132,037,000USD129,968,000USD126,831,000USD121,932,000USD
    Unclassified Equity—858,761,000USD853,957,000USD817,665,000USD806,371,001USD803,341,000USD797,133,000USD793,759,000USD
    Long Term Investments——0USD380,000USD4,632,000USD4,514,000USD5,022,000USD4,641,000USD
    Unclassified Current Liabilities———-7,700,000USD—-1,414,000USD-8,211,000USD-8,520,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets200,455,000USD285,711,000USD178,311,000USD135,619,000USD119,746,000USD122,005,000USD202,388,000USD103,559,000USD
    Other Current Assets16,022,000USD9,921,000USD11,102,000USD11,914,000USD8,702,000USD4,590,000USD1,557,000USD925,000USD
    Total Liab305,929,000USD294,514,000USD243,523,000USD224,980,000USD111,333,000USD25,650,000USD22,086,000USD13,465,000USD
    Total Stockholder Equity-105,474,000USD-8,803,000USD-65,212,000USD-89,361,000USD8,413,000USD96,355,000USD180,302,000USD90,094,000USD
    Other Current Liab34,281,000USD35,018,000USD24,698,000USD18,389,000USD16,594,000USD18,165,000USD14,788,000USD9,193,000USD
    Common Stock133,000USD115,000USD89,000USD63,000USD61,000USD60,000USD57,000USD44,000USD
    Capital Stock133,000USD115,000USD89,000USD63,000USD61,000USD60,000USD57,000USD44,000USD
    Retained Earnings-959,716,000USD-806,222,000USD-679,348,000USD-577,104,000USD-467,321,000USD-356,501,000USD-228,017,000USD-122,871,000USD
    Cash110,745,000USD171,987,000USD95,002,000USD55,408,000USD44,360,000USD52,864,000USD49,688,000USD101,318,000USD
    Cash And Short Term Investments120,456,000USD236,685,000USD136,968,000USD99,964,000USD89,139,000USD102,018,000USD147,077,000USD101,318,000USD
    Total Current Assets186,024,000USD276,135,000USD169,186,000USD128,907,000USD114,390,000USD115,619,000USD148,634,000USD102,243,000USD
    Total Current Liabilities46,418,000USD45,949,000USD31,212,000USD23,916,000USD22,380,000USD21,436,000USD19,482,000USD13,465,000USD
    Net Debt17,587,000USD-48,600,000USD4,393,000USD43,715,000USD-43,962,000USD-51,367,000USD-47,084,000USD-101,318,000USD
    Short Long Term Debt Total128,332,000USD123,387,000USD99,395,000USD99,123,000USD398,000USD1,497,000USD2,604,000USD—
    Long Term Debt122,210,000USD121,734,000USD98,551,000USD97,537,000USD————
    Long Term Investments0USD5,022,000USD4,502,000USD0USD675,000USD1,893,000USD48,555,000USD—
    Short Term Investments9,711,000USD64,698,000USD41,966,000USD44,556,000USD44,779,000USD49,154,000USD97,389,000USD—
    Net Receivables33,082,000USD20,302,000USD15,443,000USD12,704,000USD11,717,000USD7,047,000USD——
    Inventory16,464,000USD9,227,000USD5,673,000USD4,325,000USD4,832,000USD1,964,000USD——
    Accounts Payable12,137,000USD10,931,000USD6,514,000USD5,527,000USD5,786,000USD3,271,000USD4,694,000USD4,272,000USD
    Property Plant Equipment Net9,093,000USD3,789,000USD2,360,000USD3,749,000USD3,147,000USD4,204,000USD4,712,000USD948,000USD
    Property Plant Equipment Gross13,680,000USD8,070,000USD6,312,000USD1,297,000USD1,967,000USD4,204,000USD4,712,000USD948,000USD
    Accumulated Other Comprehensive Income19,000USD56,000USD12,000USD-107,000USD-25,000USD271,000USD276,000USD-747,000USD
    Common Stock Shares Outstanding48,116,098shares42,876,737shares28,834,303shares22,806,812shares22,347,481shares21,780,826shares20,528,727shares15,754,193shares
    Non Current Assets Total14,431,000USD9,576,000USD9,125,000USD6,712,000USD5,356,000USD6,386,000USD53,754,000USD1,316,000USD
    Non Current Liabilities Total259,511,000USD248,565,000USD212,311,000USD201,064,000USD88,953,000USD4,214,000USD2,604,000USD0USD
    Non Currrent Assets Other5,161,000USD765,000USD2,263,000USD2,963,000USD1,534,000USD289,000USD487,000USD317,000USD
    Net Working Capital139,606,000USD230,186,000USD137,974,000USD104,991,000USD92,010,000USD94,183,000USD129,152,000USD88,778,000USD
    Unclassified Non Current Liabilities137,301,000USD126,831,000USD113,760,000USD98,923,000USD-88,555,000USD-1,220,000USD——
    Unclassified Equity853,957,000USD797,133,000USD613,946,000USD487,724,000USD475,637,000USD452,465,000USD407,929,000USD213,624,000USD
    Current Deferred Revenue—5,151,000USD4,391,000USD618,000USD497,000USD382,000USD——
    Short Term Debt—1,530,000USD819,000USD941,000USD3,330,000USD1,859,000USD——
    Unclassified Current Liabilities—-6,681,000USD-5,210,000USD-1,559,000USD-3,827,000USD-2,241,000USD——
    Other Assets———620,000USD29,932USD289,000USD487,000USD368,000USD
    Non Current Liabilities Other———4,604,000USD88,953,000USD2,717,000USD2,604,000USD—
    Net Tangible Assets———-89,361,000USD8,413,000USD96,355,000USD180,302,000USD90,094,000USD
    Other Liab————88,555,000USD2,717,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-23,574,000USD-26,364,000USD-33,347,000USD-49,940,000USD-43,843,000USD-37,512,000USD-23,673,000USD-33,403,000USD
    Depreciation652,000USD679,000USD639,000USD596,000USD497,000USD306,000USD266,000USD263,000USD
    Stock Based Compensation4,627,000USD3,130,000USD3,027,000USD2,733,000USD3,069,000USD3,303,000USD3,489,000USD3,560,000USD
    Other Non Cash Items3,059,000USD2,490,651USD915,000USD1,546,000USD839,000USD4,794,659USD1,378,690USD3,265,000USD
    Change To Account Receivables-22,330,000USD-14,180,793USD-54,000USD-11,000USD664,000USD2,500,000USD-5,387,000USD-3,257,000USD
    Change To Inventory-4,457,000USD-8,601,979USD-1,213,000USD462,000USD1,637,000USD-1,633,000USD-152,000USD-199,000USD
    Change In Working Capital-30,080,000USD-18,260,651USD-13,504,000USD5,240,000USD-2,586,000USD15,489,341USD-9,124,690USD2,567,000USD
    Total Cash From Operating Activities-45,316,000USD-38,325,000USD-42,270,000USD-39,825,000USD-42,024,000USD-13,619,000USD-27,664,000USD-23,748,000USD
    Capital Expenditures-54,000USD-17,000USD-87,000USD-141,000USD-44,000USD-115,000USD-96,000USD-84,000USD
    Free Cash Flow-45,370,000USD-38,342,000USD-42,357,000USD-39,966,000USD-42,068,000USD-13,734,000USD-27,760,000USD-23,832,000USD
    Investments-20,634,000USD27,734,000USD31,485,000USD28,547,000USD-25,963,000USD60,621,000USD-106,750,000USD11,998,000USD
    Total Cashflows From Investing Activities-20,688,000USD27,717,000USD31,398,000USD28,406,000USD-25,963,000USD60,621,000USD-106,750,000USD11,998,000USD
    Net Borrowings65,025,000USD-1,855,000USD——0USD0USD——
    Total Cash From Financing Activities65,204,000USD31,316,000USD8,272,000USD296,000USD34,000USD71,000USD39,606,000USD100,285,000USD
    Issuance Of Capital Stock0USD31,831,000USD7,970,000USD-4,000USD4,000USD0USD15,003,000USD81,509,000USD
    Change In Cash-800,000USD20,709,000USD-2,600,000USD-11,123,000USD-67,953,000USD47,074,000USD-94,808,000USD88,535,000USD
    Begin Period Cash Flow112,095,000USD91,386,000USD93,986,000USD105,109,000USD173,062,000USD125,989,000USD220,797,000USD132,262,000USD
    End Period Cash Flow111,295,000USD112,095,000USD91,386,000USD93,986,000USD105,109,000USD173,063,000USD125,989,000USD220,797,000USD
    Other Cashflows From Financing Activities65,346,000USD33,317,413USD8,272,000USD296,000USD34,000USD175,632,934USD210,066USD18,776,000USD
    Unclassified Financing Cash Flow-65,167,000USD-31,977,413USD-7,970,000USD——-175,561,934USD24,392,934USD—
    Other Cashflows From Investing Activities—-60,032,000USD31,485,000USD28,547,000USD———12,082,000USD
    Unclassified Investing Cash Flow—60,032,000USD-31,485,000USD-28,547,000USD———-11,998,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-153,494,000USD-126,874,000USD-102,244,000USD-109,783,000USD-110,820,000USD-128,484,000USD-105,146,000USD-75,657,000USD
    Depreciation2,411,000USD1,186,000USD1,705,000USD1,817,000USD1,773,000USD2,044,000USD1,324,000USD417,000USD
    Stock Based Compensation11,959,000USD13,108,000USD9,343,000USD10,580,000USD23,113,000USD28,025,000USD29,967,000USD30,642,000USD
    Other Non Cash Items4,594,000USD10,881,000USD11,484,000USD16,133,000USD-1,176,000USD-1,541,000USD-910,000USD100,000USD
    Change To Account Receivables-12,780,000USD-4,859,000USD-2,739,000USD-987,000USD-4,671,000USD-7,047,000USD-7,047,000USD3,293,000USD
    Change To Inventory-7,237,000USD-3,554,000USD-1,348,000USD-362,000USD-2,868,000USD-1,964,000USD-1,964,000USD316,000USD
    Change In Working Capital-27,914,000USD4,933,000USD3,336,000USD-6,306,000USD-13,106,000USD-6,369,000USD4,320,000USD7,164,000USD
    Total Cash From Operating Activities-162,444,000USD-96,766,000USD-76,376,000USD-87,559,000USD-84,892,000USD-105,886,000USD-71,017,000USD-37,334,000USD
    Capital Expenditures-289,000USD-295,000USD-194,000USD-254,000USD-752,000USD-1,215,000USD-325,000USD-560,000USD
    Free Cash Flow-162,733,000USD-97,061,000USD-76,570,000USD-87,813,000USD-85,644,000USD-107,101,000USD-71,342,000USD-37,894,000USD
    Investments61,847,000USD-20,613,000USD33,499,000USD1,314,000USD4,821,000USD94,453,000USD-145,096,000USD35,901,000USD
    Total Cashflows From Investing Activities61,558,000USD-20,613,000USD-953,000USD1,060,000USD4,069,000USD93,238,000USD-145,593,000USD35,287,000USD
    Net Borrowings-1,855,000USD24,488,000USD0USD95,783,000USD0USD51,000USD—-215,000USD
    Total Cash From Financing Activities39,918,000USD194,619,000USD116,931,000USD97,134,000USD72,319,000USD16,527,000USD165,250,000USD66,421,000USD
    Issuance Of Capital Stock39,801,000USD151,169,000USD67,358,000USD0USD0USD15,853,000USD161,662,000USD64,235,000USD
    Change In Cash-60,968,000USD77,240,000USD39,602,000USD10,635,000USD-8,504,000USD3,879,000USD-51,360,000USD64,374,000USD
    Begin Period Cash Flow173,063,000USD95,823,000USD56,221,000USD45,586,000USD54,090,000USD50,211,000USD101,571,000USD37,197,000USD
    End Period Cash Flow112,095,000USD173,063,000USD95,823,000USD56,221,000USD45,586,000USD54,090,000USD50,211,000USD101,571,000USD
    Other Cashflows From Financing Activities39,918,000USD18,962,000USD49,573,000USD-160,000USD72,402,000USD674,000USD3,588,000USD2,186,000USD
    Unclassified Financing Cash Flow-37,946,000USD—————-3,588,000USD-2,186,000USD
    Unclassified Investing Cash Flow——-34,258,000USD-1,314,000USD-4,821,000USD-94,453,000USD——
    Change To Liabilities———887,000USD-561,000USD-1,245,000USD4,714,000USD6,530,000USD
    Sale Purchase Of Stock———1,351,000USD-83,000USD16,527,000USD165,250,000USD66,636,000USD
    Cash And Cash Equivalents Changes———10,635,000USD-8,504,000USD3,879,000USD-51,360,000USD64,374,000USD
    Other Cashflows From Investing Activities———1,314,000USD4,821,000USD94,453,000USD-172,000USD-54,000USD
    Unclassified Operating Cash Flow————15,324,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductJelmyto22,028,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductZusduri50,429,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductJelmyto21,713,000USD0001437749-26-015019
    Q1 2026Quarterly · 2026-03-31ProductZusduri29,246,000USD0001437749-26-015019
    FY 2025Yearly · 2025-12-31ProductJelmyto93,989,000USD0001437749-26-006234
    FY 2025Yearly · 2025-12-31ProductZusduri15,799,000USD0001437749-26-006234
    Q3 2025Quarterly · 2025-09-30ProductJelmyto25,703,000USD0001437749-25-033468
    Q3 2025Quarterly · 2025-09-30ProductZusduri1,779,000USD0001437749-25-033468
    Q1 2025Quarterly · 2025-03-31ProductJelmyto20,254,000USD0001437749-26-015019
    Q1 2025Quarterly · 2025-03-31ProductZusduri0USD0001437749-26-015019
    FY 2024Yearly · 2024-12-31ProductJelmyto90,398,000USD0001437749-26-006234
    FY 2024Yearly · 2024-12-31ProductZusduri0USD0001437749-26-006234
    Q3 2024Quarterly · 2024-09-30ProductJelmyto25,204,000USD0001437749-25-033468
    Q3 2024Quarterly · 2024-09-30ProductZusduri0USD0001437749-25-033468

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.